cdna
clone
span
entir
region
peplom
gene
felin
infecti
periton
viru
fipv
type
strain
obtain
complet
nucleotid
sequenc
determin
long
open
read
frame
orf
encod
amino
acid
residu
found
gene
residu
longer
orf
fipv
type
ii
strain
sequenc
fipv
type
mainli
fipv
type
ii
compar
homolog
n
amino
acid
residu
c
residu
termin
halv
respect
much
lower
fipv
type
ii
antigen
relat
coronavirus
transmiss
gastroenter
viru
swine
canin
coronaviru
support
serolog
related
virus
confirm
peplom
protein
fipv
type
distinct
structur
featur
differ
antigen
relat
virus
felin
infecti
periton
fip
virusinduc
chronic
progress
usual
fatal
diseas
domest
wild
felida
caus
agent
diseas
fip
viru
fipv
belong
famili
coronavirida
fipv
form
relat
antigen
cluster
felin
enter
coronaviru
transmiss
gastroenter
viru
tgev
swine
canin
coronaviru
ccv
porcin
respiratori
coronaviru
prcv
fipv
two
serolog
subtyp
type
type
ii
caus
similar
diseas
anim
survey
antibodi
posit
cat
japan
fip
infect
type
ii
respect
fipv
envelop
rna
viru
singlestrand
positivesens
rna
genom
fipv
virion
consist
three
main
structur
protein
peplom
protein
membran
protein
nucleocapsid
n
protein
comparison
antigen
n
protein
fipv
type
ii
reveal
k
motokawa
et
al
serolog
close
relat
howev
peplom
protein
homolog
viru
genom
kilobas
kb
tong
three
major
structur
protein
gene
locat
half
genom
complet
nucleotid
sequenc
gene
establish
fipv
type
ii
strain
sever
serolog
relat
coronavirus
also
investig
molecularli
tgev
ccv
date
immun
fip
avail
antibodydepend
enhanc
ade
phenomenon
due
humor
antibodi
clarifi
involv
virion
antigen
phenomenon
vennema
collabor
clone
cdna
n
protein
gene
fipv
construct
recombin
vaccinia
virus
contain
one
cdna
recombin
virus
use
immun
subsequ
viru
challeng
kitten
author
indic
peplom
protein
might
respons
phenomenon
fipv
type
ii
preferenti
use
experiment
materi
probabl
prolif
effici
fipv
type
ii
cultur
cell
much
higher
type
thu
type
littl
investig
especi
molecular
biolog
level
therefor
seem
import
studi
fipv
type
preval
japan
type
ii
studi
cdna
clone
sequenc
peplom
gene
fipv
type
compar
relat
virus
studi
confirm
serolog
related
fipv
type
coronavirus
viru
genom
rna
fipv
type
strain
isol
propag
feli
catu
whole
fetu
cell
fcwf
virusinfect
cell
homogen
dounc
type
homogen
celt
nuclei
remov
low
speed
centrifug
virion
supernat
pellet
layer
sucros
centrifug
x
g
viru
genom
rna
extract
viru
pellet
sdsphenol
precipit
ethanol
dna
primer
customsynthes
bex
corp
tokyo
use
diamidit
chemistri
automat
dna
synthes
two
minussens
primer
prepar
clone
studi
one
locat
downstream
use
revers
transcript
locat
upstream
subsequ
pcr
nucleotid
sequenc
posit
primer
shown
tabl
primer
creat
refer
nucleotid
sequenc
protein
gene
fipv
strain
genom
templat
rna
fipv
type
strain
revers
transcrib
negativesens
downstream
dna
primer
templat
rna
digest
naoh
h
poli
da
tail
ad
singlestrand
cdna
use
termin
deoxynucleotidyl
transferas
poli
datail
cdna
amplifi
pcr
prime
anoth
upstream
primer
oligo
primer
recognit
site
restrict
enzym
bamhi
ecori
psti
dna
fragment
larger
pair
obtain
electrophoresi
low
melt
point
agaros
digest
restrict
enzym
clone
restrict
site
cdna
clone
select
sequenc
nucleotid
end
contain
primer
sequenc
clone
cdna
subclon
singlestrand
dna
sequenc
restrict
site
use
obtain
cdna
fragment
shown
fig
dna
sequenc
mean
dideoxynucleotid
chain
termin
use
dye
primer
cycl
sequenc
kit
appli
biosystem
sequenc
resolv
autom
dna
sequenc
appli
biosystem
model
sequenc
determin
analyz
genetyx
comput
program
softwar
develop
co
ltd
homolog
includ
delet
sequenc
calcul
nucleotid
sequenc
data
report
paper
appear
gsdb
ddbj
embl
ncbi
nucleotid
sequenc
databas
access
number
sinc
fipv
type
prolifer
slowli
type
ii
easi
obtain
larg
quantiti
purifi
virus
use
pcr
gener
suffici
cdna
viral
templat
first
cdna
synthes
minusstrand
dna
primer
end
necessari
revers
transcript
pcr
prepar
basi
nucleotid
sequenc
fipv
strain
gene
poli
da
tail
ad
singlestrand
cdna
use
termin
deoxynucleotidyl
transferas
oligo
use
plusstrand
primer
pcr
amplifi
cdna
molecularli
clone
multipl
clone
site
nucleotid
sequenc
end
clone
determin
clone
contain
nucleotid
sequenc
primer
end
select
contain
end
reter
prepar
dna
primer
next
cdna
clone
cdna
clone
experi
henc
perform
sequenti
final
five
cdna
clone
four
cover
entir
peplom
gene
isol
shown
fig
complet
nucleotid
sequenc
peplom
gene
fipv
type
determin
sequenc
cdna
clone
least
five
clone
one
type
cdna
sequenc
avoid
artifact
mutat
due
misread
revers
transcriptas
taq
polymeras
pcr
long
open
read
frame
orf
found
extend
second
fifth
cdna
consid
peplom
protein
fipv
type
orf
base
amino
acid
residu
long
equival
tabl
predict
protein
kda
gene
base
longer
amino
acid
fipv
type
ii
report
de
groot
et
al
total
nucleotid
deduc
amino
acid
sequenc
orf
peplom
gene
fipv
type
shown
fig
peplom
protein
fipv
type
also
two
hydrophob
segment
characterist
type
membran
protein
ntermin
signal
sequenc
residu
transmembran
domain
residu
amino
acid
sequenc
homolog
latter
complet
conserv
former
downstream
transmembran
domain
mani
cystein
residu
similar
ntermin
signal
sequenc
ctermin
transmembran
domain
cystein
cluster
present
peplom
protein
fipv
type
ii
ccv
tgev
fortyon
potenti
nglycosyl
site
nx
present
overal
peplom
protein
six
site
fewer
type
ii
locat
good
accord
ctermin
part
less
ntermin
part
peplom
protein
fipv
type
ii
tgev
cleav
host
cell
proteinas
peplom
protein
fipv
type
sequenc
identifi
cleavag
motif
rrfrr
avian
infecti
bronchiti
viru
except
tetranucleotid
sequenc
rrsr
residu
vestigi
cleavag
site
noncod
region
nucleotid
orf
amino
acid
fipv
type
ii
peplom
protein
gene
align
fig
noncod
region
well
conserv
noncod
region
gggtaaaatactcaagttggtga
ctcggtmt
cacgcacac
catta
cattacacact
ccagc
g
f
l
l
l
v
ngagggttmaagggmgatagtagattftgtcatcctatactatgccactlttaacatcaaaat
tgaaagattcaatgccacagctttaggtggtgaaaagctaggc
ggittata
gatggc
ctgagcagtctattac
c
gc
ctaaaaggtaagaggtc
g
l
g
g
e
k
l
g
g
l
f
g
l
l
k
p
p
k
g
k
r
e
r
f
gctgttgaagatctattgttcaataaagtggtgac
cagcggtcttggcactgttgatgatgactataaaaagtgctcttcc
ggcactgacgttgcagatc
v
e
l
l
f
n
k
v
v
g
l
g
v
k
k
c
g
v
l
tagtttgtgc
ccaataacaatggcataatggttttacctggtggt
ggatg
gtaataagatgtctatgtacactgcatctttaattggcggtatggc
v
c
g
f
c
g
ggaagaagtgac
e
e
v
w
g
c
v
ti
tt
ct
ctttgta
gtagaag
gcaatttgaaac
ctat
gaa
c
c
cattgaaaag
gtt
ca
cattcaifaacta
gac
galrtatg
gata
ctgt
caagt
ctattg
g
ca
tctctgtggacgctgtaci
fgacgagttaaattccg
homolog
low
ntermin
half
higher
ctermin
half
sequenc
homolog
data
peplom
protein
analyz
summar
tabl
tabl
fipv
type
compar
fipv
type
ii
tgev
ccv
amino
acid
sequenc
homolog
entir
peplom
protein
area
viru
fipv
type
tabl
tabl
show
homolog
ntermin
residu
amino
acid
sequenc
ctermin
amino
acid
sequenc
fipv
type
ctermin
half
show
high
homolog
fipv
type
ii
ccv
tgev
fipv
type
show
homolog
virus
tabl
also
show
fipv
type
distinct
three
coronavirus
term
amino
acid
sequenc
homolog
peplom
protein
studi
first
establish
cdna
clone
sequenc
nucleotid
peplom
protein
gene
fipv
type
compar
sequenc
fipv
type
antigen
relat
virus
famili
coronavirida
fipv
form
relat
serolog
cluster
tgev
ccv
prcv
coronaviru
famili
cluster
fipv
type
consid
discrimin
tgev
ccv
even
fipv
type
ii
base
upon
reactiv
establish
monoclon
antibodi
peplom
protein
jacob
et
al
report
great
diverg
homolog
fipv
ii
tgev
first
ntermin
part
peplom
protein
despit
high
level
conserv
amino
acid
substitut
residu
ctermin
part
state
diverg
could
deriv
select
neutral
antibodi
would
gener
recombin
relat
viru
howev
much
larger
divers
found
correspond
region
residu
fipv
type
ii
homolog
residu
ntermin
part
residu
also
low
furthermor
shown
tabl
amino
acid
sequenc
homolog
high
peplom
protein
among
fipv
type
ii
tgev
ccv
homolog
entir
peplom
protein
fipv
type
ii
ccv
fipv
type
ii
tgev
contrast
homolog
fipv
type
ii
entir
region
ctermin
half
residu
ntermin
half
residu
consequ
amino
acid
sequenc
fipv
type
ii
peplom
protein
much
homolog
ccv
tgev
fipv
type
result
support
serolog
related
reveal
extens
heterogen
peplom
protein
fipv
type
within
cluster
found
greater
divers
correspond
region
fipv
type
ii
diverg
ntermin
domain
probabl
involv
construct
globular
head
structur
coronaviru
peplom
protein
structur
must
import
role
viru
infect
virus
attach
cellular
receptor
site
unlik
virion
fipv
type
bind
receptor
cellular
membran
ade
phenomenon
hinder
control
fip
immun
vaccin
fact
neither
inactiv
virion
recombin
antigen
vaccinia
viru
vector
induc
protect
vaccin
anim
subsequ
viru
challeng
vennema
et
al
postul
peplom
protein
respons
phenomenon
protein
also
thought
suitabl
use
fip
vaccin
whether
epitop
respons
ade
protect
viral
infect
separ
fundament
problem
develop
usabl
fip
vaccin
present
conclus
inform
even
protect
vaccin
either
type
fipv
develop
futur
one
type
also
requir
peplom
protein
quit
differ
sinc
fip
usual
fatal
diseas
morbid
rate
low
effect
vaccin
desir
control
diseas
